Consensus Formycon AG

Equities

Market Closed - Xetra Other stock markets 11:36:22 2024-04-25 am EDT			5-day change	1st Jan Change
39.7 ^EUR	+1.53%		0.00%	-29.61%

Apr. 25	Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 18	Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar	MT

6e73a0f25e90.yztZn-qMs6GRe5t1IvwWow71_rU37SCJqzjHfkJtZYI.v08s8rrJhODkPKoPTrNP5WOMt91YrGH75EilDSEiMbD4YinMstrx4_Ih_A~23c3b9dd6968c2a6339d1a2f8d24bb1a

23-05-22

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

39.7 EUR

Average target price

94.2 EUR

Spread / Average Target

+137.28%

High Price Target

101 EUR

Spread / Highest target

+154.41%

Low Price Target

89 EUR

Spread / Lowest Target

+124.18%

Trading Rating

Investor Rating

ESG Refinitiv